Table 2 Patients who treated with trastuzumab and had recurrence

From: Breast carcinoma with amplified HER2: a gene expression signature specific for trastuzumab resistance and poor prognosis

Patient a

Age

Type of surgery

Hormone receptor

Stage

Site of recurrence

DFS (months)

1

46

Mastectomy

Positive

2

Multiple organs

3

2

52

Conservative

Positive

3

Brain

18

3

44

Conservative

Positive

3

Breast

19

4

51

Conservative

Negative

3

None

41

5

52

Conservative

Negative

2

None

51

6

41

Conservative

Positive

3

None

56

7

47

Mastectomy

Positive

2

None

44

8

34

Mastectomy

Negative

3

None

35

9

44

Mastectomy

Positive

2

None

42

10

28

Mastectomy

Negative

3

None

34

11

58

Conservative

Positive

3

None

34

12

75

Conservative

Positive

2

None

33

  1. aAll patients treated with adjuvant therapy in addition to trastuzumab.